Oruka Therapeutics, Inc. ORKA Unrealized Losses on Investments (Before Tax)
Unrealized Losses on Investments (Before Tax) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax)?
- Oruka Therapeutics, Inc. (ORKA) reported unrealized losses on investments (before tax) of $553K in Q1 2026.
- How has Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax) changed year-over-year?
- Oruka Therapeutics, Inc.'s unrealized losses on investments (before tax) increased by 1102.2% year-over-year, from $46K to $553K.
- What does unrealized losses on investments (before tax) mean?
- This represents the cumulative decrease in the fair market value of investment securities held by the company, measured before accounting for tax effects. It highlights potential volatility in the company's investment portfolio and the impact of market fluctuations on equity.